Search

everythinglearnresearchcommunity

for

Search:↓

Cronkhite-Canada Syndrome often leads to death within 6-18 months.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

The document concludes that accurate diagnosis of hair loss in children is crucial due to limited treatment options and the condition's psychological impact.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Genetic discoveries are key for understanding, diagnosing, and treating inherited hair and nail disorders.

A mother and son both had ulcerative colitis and alopecia, suggesting a genetic link in autoimmune disorders and successful treatment with cyclosporine.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

A patient with Sézary syndrome showed improvement after treatment and the study suggested follicular mucinosis might indicate future lymphoma risk.

Effective treatments for severe alopecia areata are still lacking.

Trichotillomania, a disorder where people compulsively pull out their own hair, often starts around age 12, is more common in adult females, and can be treated with behavior therapy and medication.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

A patient had both chronic cutaneous lupus erythematosus and frontal fibrosing alopecia.

Two patients with skin lupus were mistakenly thought to have a different scalp condition but improved with lupus treatment.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

Some topical treatments like corticosteroids and vitamin D analogues are effective for scalp psoriasis, but more long-term data is needed.

Eyelash alopecia areata often goes undiagnosed and can lead to complete eyelash regrowth, especially in younger patients.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Androgens can cause hair growth in some areas but hair loss on the scalp.

Diabetes can lead to blindness and skin problems, and managing blood sugar and blood pressure is crucial to prevent these complications.

Skin abnormalities can indicate immunodeficiency due to shared origins with the immune system.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

People with Mucopolysaccharidoses often have skin problems like thick skin and extra hair, and recognizing these can help diagnose and treat the condition early.

People with Myotonic Dystrophy type 1 are more likely to have certain skin conditions, but not more likely to get skin cancer.

Androgens can both increase body hair and cause scalp hair loss.

Low-dose oral isotretinoin improved hair loss and facial bumps in patients with a specific type of hair loss.

The report suggests that hair loss in Cronkhite-Canada syndrome may be caused by alopecia areata incognita, as shown by a patient's improvement with treatment.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.